The Clinical and Development team at Denali Therapeutics is responsible for spearheading the design, execution, and oversight of both early and late-stage clinical trials, along with regulatory compliance and safety monitoring. This team collaborates across scientific discovery, clinical manufacturing, translational medicine, and drug safety to advance potential treatments from the laboratory through to approval, ensuring the delivery of safe and effective therapies for neurodegenerative diseases.
Chris Koth
VP, Discovery Sciences
Erica Kratz
Senior Vice President, Regulat...
Kirk Henne
SVP, Development Sciences
Leah Frautschy
Vice President, Clinical Manuf...
Matt Troyer
SVP, Translational Medicine & ...
Michelle Polowski
SVP, Development Operations
Pearline Brown
Associate Director Of Clinical...
Peter Chin
Sr. Vice President & Head Of L...
Sheri Clemente
Associate Director, Talent Acq...
Wei Dong
VP, Drug Safety
View all